$DX
DYNEX CAPITAL INC

2024 Q3 Form 10-Q Financial Statement

#000082667524000093 Filed on July 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $83.46M $74.55M
YoY Change 31.91% -893.99%
Cost Of Revenue $82.56M $74.77M
YoY Change 25.99% 65.63%
Gross Profit $894.0K -$219.0K
YoY Change -139.52% -99.6%
Gross Profit Margin 1.07% -0.29%
Selling, General & Admin $8.271M $6.642M
YoY Change 5.48% -7.71%
% of Gross Profit 925.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $433.0K $424.0K
YoY Change -20.7% -30.26%
% of Gross Profit 48.43%
Operating Expenses $8.707M $7.243M
YoY Change 0.75% -5.1%
Operating Profit -$7.813M -$7.462M
YoY Change -28.35% -88.0%
Interest Expense $38.81M -$842.0K
YoY Change -40.78% -100.72%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $31.00M -$8.304M
YoY Change -172.0% -115.28%
Income Tax
% Of Pretax Income
Net Earnings $29.07M -$10.23M
YoY Change -167.53% -119.51%
Net Earnings / Revenue 34.84% -13.72%
Basic Earnings Per Share $0.38 -$0.15
Diluted Earnings Per Share $0.38 -$0.15
COMMON SHARES
Basic Shares Outstanding 74.71M shares 64.16M shares
Diluted Shares Outstanding 76.37M shares 66.95M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $268.3M $286.1M
YoY Change -1.06% -4.66%
Cash & Equivalents $268.3M $286.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $60.74M $55.70M
Other Receivables $0.00 $0.00
Total Short-Term Assets $329.0M $341.8M
YoY Change 10.44% 5.35%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $7.328B $6.193B
YoY Change 31.23% 22.41%
Other Assets $137.3M $123.1M
YoY Change -5.49% -7.17%
Total Long-Term Assets $7.487B $6.342B
YoY Change 30.37% 21.92%
TOTAL ASSETS
Total Short-Term Assets $329.0M $341.8M
Total Long-Term Assets $7.487B $6.342B
Total Assets $7.816B $6.684B
YoY Change 29.39% 20.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $48.57M $54.57M
YoY Change 12.51% 61.47%
Deferred Revenue
YoY Change
Short-Term Debt $6.424B $5.494B
YoY Change 28.42% 30.76%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.654B $5.611B
YoY Change 31.62% 32.18%
LONG-TERM LIABILITIES
Long-Term Debt $7.895M $19.38M
YoY Change
Other Long-Term Liabilities $11.97M $7.571M
YoY Change -93.39% -98.11%
Total Long-Term Liabilities $19.86M $26.95M
YoY Change -89.03% -93.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.654B $5.611B
Total Long-Term Liabilities $19.86M $26.95M
Total Liabilities $6.674B $5.638B
YoY Change 27.45% 21.39%
SHAREHOLDERS EQUITY
Retained Earnings -$507.2M -$506.1M
YoY Change 4.9% 21.4%
Common Stock $1.677B $1.620B
YoY Change 20.02% 18.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.143B $1.045B
YoY Change
Total Liabilities & Shareholders Equity $7.816B $6.684B
YoY Change 29.39% 20.95%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $29.07M -$10.23M
YoY Change -167.53% -119.51%
Depreciation, Depletion And Amortization $433.0K $424.0K
YoY Change -20.7% -30.26%
Cash From Operating Activities -$2.255M $18.61M
YoY Change -121.68% -40.91%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$955.2M -$335.3M
YoY Change 14.49% -72.91%
Cash From Investing Activities -$955.2M -$335.3M
YoY Change 14.49% -72.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 953.8M 307.6M
YoY Change 18.1% -75.29%
NET CHANGE
Cash From Operating Activities -2.255M 18.61M
Cash From Investing Activities -955.2M -335.3M
Cash From Financing Activities 953.8M 307.6M
Net Change In Cash -3.671M -9.066M
YoY Change -77.5% -123.17%
FREE CASH FLOW
Cash From Operating Activities -$2.255M $18.61M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4460000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4460000 shares
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
527000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
445000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
51868000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
45971000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1517394000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
432754000 usd
CY2023Q4 us-gaap Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
6038948000 usd
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0 usd
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
5381104000 usd
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
5381104000 usd
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
48745000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57038247 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57038247 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
901328000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2771000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
360000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
650000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
276000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
16000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-41722000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1923000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21137000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14793000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
854828000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3543000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
296000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
833000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
169000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
16000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
54337000 usd
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1923000 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21324000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9443000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
880962000 usd
us-gaap Net Income Loss
NetIncomeLoss
31815000 usd
us-gaap Net Income Loss
NetIncomeLoss
12616000 usd
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-1506000 usd
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-74916000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-112001000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
57609000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
165771000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
48745000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
26483000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
38924000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
925000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1193000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5184000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2140000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-404000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
7728000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1373000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17344000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
12415000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2176000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1505000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35227000 usd
us-gaap Payments To Acquire Trading Securities Heldforinvestment
PaymentsToAcquireTradingSecuritiesHeldforinvestment
501921000 usd
us-gaap Payments To Acquire Trading Securities Heldforinvestment
PaymentsToAcquireTradingSecuritiesHeldforinvestment
2109585000 usd
us-gaap Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment
ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment
186048000 usd
us-gaap Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment
ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment
73849000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
37948000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
47919000 usd
us-gaap Proceeds From Sale Of Trading Securities Heldforinvestment
ProceedsFromSaleOfTradingSecuritiesHeldforinvestment
13782000 usd
us-gaap Proceeds From Sale Of Trading Securities Heldforinvestment
ProceedsFromSaleOfTradingSecuritiesHeldforinvestment
348091000 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
441000 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
502000 usd
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-187635000 usd
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-64290000 usd
us-gaap Increase Decrease Cash Collateral From Counterparties
IncreaseDecreaseCashCollateralFromCounterparties
-26618000 usd
us-gaap Increase Decrease Cash Collateral From Counterparties
IncreaseDecreaseCashCollateralFromCounterparties
5190000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102685000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1569744000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
27001079000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
10999164000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
26887755000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
9441668000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
211650000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6314000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
272579000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
171399000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17123000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237864000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
449877000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
409263000 usd
us-gaap Interest Paid Net
InterestPaidNet
148111000 usd
us-gaap Interest Paid Net
InterestPaidNet
59105000 usd
us-gaap Nature Of Operations
NatureOfOperations
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dynex Capital, Inc. (the “Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company is an internally managed mortgage real estate investment trust, or mortgage REIT, which primarily earns income from investing on a leveraged basis in Agency mortgage-backed securities (“Agency MBS”) and in to-be-announced securities (“TBAs” or “TBA securities”). Agency MBS have a guaranty of principal and interest payments by a U.S. government-sponsored entity (“GSE”) such as Fannie Mae and Freddie Mac, which are in conservatorship and are currently supported by a senior preferred stock purchase agreement from the U.S. Treasury. As of June 30, 2024, the majority of the Company’s Agency MBS are secured by residential real property (“Agency RMBS”). The remainder of the Company’s investments are in Agency commercial MBS (“Agency CMBS”) and in both Agency and non-Agency CMBS interest-only (“CMBS IO”). Non-Agency MBS do not have a GSE guaranty of principal or interest payments.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, amortization of premiums and discounts and fair value measurements of its investments, including TBA securities accounted for as derivative instruments. These items are discussed further below within this note to the consolidated financial statements. The Company believes the estimates and assumptions underlying the consolidated financial statements included herein are reasonable and supportable based on the information available as of June 30, 2024.
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
286132000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
123131000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
409263000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2300000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
58503 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66954870 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54137327 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63003545 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53981463 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66954870 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54585082 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63913156 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54327385 shares
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10227000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
52414000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
27968000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8769000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1110206 shares
CY2024Q2 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
6456137000 usd
CY2024Q2 dx Debt Securities Trading And Available For Sale Amortized Cost
DebtSecuritiesTradingAndAvailableForSaleAmortizedCost
6568580000 usd
CY2024Q2 us-gaap Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
6193139000 usd
CY2023Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
6143945000 usd
CY2023Q4 dx Debt Securities Trading And Available For Sale Amortized Cost
DebtSecuritiesTradingAndAvailableForSaleAmortizedCost
6283185000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1067477000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1359000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
178914000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
889922000 usd
CY2024Q2 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
5501103000 usd
CY2024Q2 dx Gross Unrealized Gain Investment Fair Value Option
GrossUnrealizedGainInvestmentFairValueOption
13333000 usd
CY2024Q2 dx Gross Unrealized Loss Investment Fair Value Option
GrossUnrealizedLossInvestmentFairValueOption
211219000 usd
CY2024Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
5303217000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1131769000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1324000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
159826000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
973267000 usd
CY2023Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
5151416000 usd
CY2023Q4 dx Gross Unrealized Gain Investment Fair Value Option
GrossUnrealizedGainInvestmentFairValueOption
48461000 usd
CY2023Q4 dx Gross Unrealized Loss Investment Fair Value Option
GrossUnrealizedLossInvestmentFairValueOption
134196000 usd
CY2023Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
5065681000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-41977000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
488000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-112001000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
57609000 usd
CY2024Q2 us-gaap Debt Securities Trading Realized Loss
DebtSecuritiesTradingRealizedLoss
1506000 usd
CY2023Q2 us-gaap Debt Securities Trading Realized Loss
DebtSecuritiesTradingRealizedLoss
51601000 usd
us-gaap Debt Securities Trading Realized Loss
DebtSecuritiesTradingRealizedLoss
1506000 usd
us-gaap Debt Securities Trading Realized Loss
DebtSecuritiesTradingRealizedLoss
74916000 usd
CY2024Q2 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-1506000 usd
CY2023Q2 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-51601000 usd
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-1506000 usd
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-74916000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2024Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
5494428000 usd
CY2024Q2 us-gaap Assets Sold Under Agreements To Repurchase Interest Rate
AssetsSoldUnderAgreementsToRepurchaseInterestRate
0.0546
CY2024Q2 us-gaap Transfers Accounted For As Secured Borrowings Assets Carrying Amount
TransfersAccountedForAsSecuredBorrowingsAssetsCarryingAmount
5788148000 usd
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
5381104000 usd
CY2023Q4 us-gaap Assets Sold Under Agreements To Repurchase Interest Rate
AssetsSoldUnderAgreementsToRepurchaseInterestRate
0.0559
CY2023Q4 us-gaap Transfers Accounted For As Secured Borrowings Assets Carrying Amount
TransfersAccountedForAsSecuredBorrowingsAssetsCarryingAmount
5880747000 usd
CY2024Q2 dx Number Of Counterparties Borrowings Outstanding
NumberOfCounterpartiesBorrowingsOutstanding
28 counterparty
CY2024Q2 us-gaap Securities Received As Collateral
SecuritiesReceivedAsCollateral
2400000 usd
CY2024Q2 us-gaap Collateral Securities Repledged Delivered Or Used
CollateralSecuritiesRepledgedDeliveredOrUsed
0 usd
CY2024Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
5494428000 usd
CY2024Q2 us-gaap Assets Sold Under Agreements To Repurchase Interest Rate
AssetsSoldUnderAgreementsToRepurchaseInterestRate
0.0546
CY2024Q2 dx Originaltermtomaturity
Originaltermtomaturity
94
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
5381104000 usd
CY2023Q4 us-gaap Assets Sold Under Agreements To Repurchase Interest Rate
AssetsSoldUnderAgreementsToRepurchaseInterestRate
0.0559
CY2023Q4 dx Originaltermtomaturity
Originaltermtomaturity
89
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
54600000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
53200000 usd
CY2024Q2 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
5494428000 usd
CY2024Q2 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0 usd
CY2024Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
5494428000 usd
CY2024Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
5494428000 usd
CY2024Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0 usd
CY2024Q2 us-gaap Security Sold Under Agreement To Repurchase After Offset And Deduction Subject To Master Netting Arrangement
SecuritySoldUnderAgreementToRepurchaseAfterOffsetAndDeductionSubjectToMasterNettingArrangement
0 usd
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
5381104000 usd
CY2023Q4 us-gaap Security Sold Under Agreement To Repurchase After Offset And Deduction Subject To Master Netting Arrangement
SecuritySoldUnderAgreementToRepurchaseAfterOffsetAndDeductionSubjectToMasterNettingArrangement
0 usd
CY2024Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
41135000 usd
CY2023Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
116012000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
165771000 usd
CY2024Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
8461000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
54361000 usd
CY2024Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
2032000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
0 usd
CY2024Q2 us-gaap Margin Deposit Assets
MarginDepositAssets
122200000 usd
CY2023Q4 us-gaap Margin Deposit Assets
MarginDepositAssets
118200000 usd
CY2024Q2 us-gaap Variation Margin Receivable Derivative
VariationMarginReceivableDerivative
20400000 usd
CY2023Q4 us-gaap Variation Margin Receivable Derivative
VariationMarginReceivableDerivative
1300000 usd
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
8461000 usd
CY2024Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 usd
CY2024Q2 us-gaap Derivative Assets
DerivativeAssets
8461000 usd
CY2024Q2 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
2032000 usd
CY2024Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
6311000 usd
CY2024Q2 us-gaap Derivative Asset Fair Value After Offset And Deduction Subject To Master Netting Arrangement
DerivativeAssetFairValueAfterOffsetAndDeductionSubjectToMasterNettingArrangement
118000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
54361000 usd
CY2023Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
54361000 usd
CY2023Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
0 usd
CY2023Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
44153000 usd
CY2023Q4 us-gaap Derivative Asset Fair Value After Offset And Deduction Subject To Master Netting Arrangement
DerivativeAssetFairValueAfterOffsetAndDeductionSubjectToMasterNettingArrangement
10208000 usd
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2032000 usd
CY2024Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2024Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2032000 usd
CY2024Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
2032000 usd
CY2024Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 usd
CY2024Q2 us-gaap Derivative Liability Fair Value After Offset And Deduction Subject To Master Netting Arrangement
DerivativeLiabilityFairValueAfterOffsetAndDeductionSubjectToMasterNettingArrangement
0 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
0 usd
CY2023Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2023Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
0 usd
CY2023Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 usd
CY2023Q4 us-gaap Derivative Liability Fair Value After Offset And Deduction Subject To Master Netting Arrangement
DerivativeLiabilityFairValueAfterOffsetAndDeductionSubjectToMasterNettingArrangement
0 usd
CY2024Q2 dx Loans Held For Investment Fair Value Option Measurement Input
LoansHeldForInvestmentFairValueOptionMeasurementInput
0.10
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
900000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5200000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2100000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
7421000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000826675-24-000093-index-headers.html Edgar Link pending
0000826675-24-000093-index.html Edgar Link pending
0000826675-24-000093.txt Edgar Link pending
0000826675-24-000093-xbrl.zip Edgar Link pending
dx-20240630.htm Edgar Link pending
dx-20240630.xsd Edgar Link pending
dx-20240630_g1.jpg Edgar Link pending
dx-20240630_g2.jpg Edgar Link pending
dx-20240630_g3.jpg Edgar Link pending
exhibit101employmentagreem.htm Edgar Link pending
exhibit102employmentagreem.htm Edgar Link pending
exhibit103employmentagreem.htm Edgar Link pending
exhibit311ceocertification.htm Edgar Link pending
exhibit312ceocertification.htm Edgar Link pending
exhibit313cfocertification.htm Edgar Link pending
exhibit321soxcertification.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
dx-20240630_cal.xml Edgar Link unprocessable
dx-20240630_def.xml Edgar Link unprocessable
dx-20240630_lab.xml Edgar Link unprocessable
dx-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dx-20240630_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending